# Detection of differential bait proteoforms through immunoprecipitation-mass spectrometry data analysis

**Authors:** Savvas Kourtis, Damiano Cianferoni, Luis Serrano, Sara Sdelci

PMC · DOI: 10.1038/s41597-024-03394-x · Scientific Data · 2024-05-29

## TL;DR

This paper introduces a new method to analyze protein interactions using mass spectrometry, focusing on how specific protein forms change under different conditions.

## Contribution

The novel workflow identifies differential peptidoforms of bait proteins in IP-MS data, offering insights into pathogenic protein states.

## Key findings

- A new IP-MS data analysis workflow focuses on bait proteoform changes across conditions.
- The method reveals detailed information about specific bait proteoforms linked to cellular functions.
- This approach can help identify protein states useful for targeted therapy development.

## Abstract

Proteins are often referred to as the workhorses of cells, and their interactions are necessary to facilitate specific cellular functions. Despite the recognition that protein-protein interactions, and thus protein functions, are determined by proteoform states, such as mutations and post-translational modifications (PTMs), methods for determining the differential abundance of proteoforms across conditions are very limited. Classically, immunoprecipitation coupled with mass spectrometry (IP-MS) has been used to understand how the interactome (preys) of a given protein (bait) changes between conditions to elicit specific cellular functions. Reversing this concept, we present here a new workflow for IP-MS data analysis that focuses on identifying the differential peptidoforms of the bait protein between conditions. This method can provide detailed information about specific bait proteoforms, potentially revealing pathogenic protein states that can be exploited for the development of targeted therapies.

## Full-text entities

- **Genes:** BRD4 (bromodomain containing 4) [NCBI Gene 23476] {aka CAP, CDLS6, FSHRG4, HUNK1, HUNKI, MCAP}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1) [NCBI Gene 4522] {aka CIMAH, MTHFC, MTHFD}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}
- **Diseases:** leukemia (MESH:D007938), cancer (MESH:D009369)
- **Chemicals:** carbons (MESH:D002244), GDP (MESH:D006153), cysteic acid (MESH:D003544), Cysteine (MESH:D003545), AMG-510 (MESH:C000706028), AminoLink resin (-), iodoacetamide (MESH:D007460), sulfinic acid (MESH:D013441), methionine (MESH:D008715), DTT (MESH:D004229), agarose (MESH:D012685), nucleotide (MESH:D009711), Urea (MESH:D014508), acids (MESH:D000143)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Serine 118 was mutated to Cysteine, A301-985 A, G12, G-> D, G12C
- **Cell lines:** MOM-13 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_1081), K-562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), CAL-33 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_1108), MEG-01 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0425), MOLM-13 — Homo sapiens (Human), Adult acute monocytic leukemia, Cancer cell line (CVCL_2119), SCC-25 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_1682), HET-1A — Homo sapiens (Human), Transformed cell line (CVCL_3702)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11137132/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11137132/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC11137132/full.md

---
Source: https://tomesphere.com/paper/PMC11137132